Liver cancer PDX model

Patient-derived xenograft (PDX) models have become a crucial tool in preclinical cancer research, providing a more accurate representation of human tumors. Liver cancer PDX models are particularly valuable for studying hepatocellular carcinoma (HCC) and other liver malignancies, allowing researchers to test new therapies in a biologically relevant environment. By maintaining the tumor's original characteristics, these models help in evaluating drug efficacy and resistance mechanisms. As the demand for personalized medicine grows, liver cancer PDX models play a key role in bridging the gap between laboratory research and clinical applications.